The World Health Organization (WHO) issued an alert about counterfeit Ozempic infiltrating the regulated supply chain, found in countries like the US, Brazil, UK, and Northern Ireland.
Insulin, a synthetic version of the hormone taken by diabetics, was discovered in some contaminated drugs, posing risks due to incorrect dosage.
WHO acknowledged investigating the counterfeit Ozempic issue, which is sold by Novo Nordisk; FDA and the UK issued their alerts about falsified batches.
[
Collection
]
[
|
...
]